English
Alivus Life Sciences Q4 Results
- BSE: 543322
- NSE: ALIVUS
- ISIN: INE03Q201024
- Sector: Biotechnology & Drugs
BSE
880.55
9.95 (1.14%)
9.95 (1.14%)Volume3.65 K
Updated: Fri 5 Dec, 2025 | 15:28:00
NSE
883.7511.70 (1.34%)
11.70 (1.34%)Volume1.84 L
Updated: Fri 5 Dec, 2025 | 15:40:06
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Alivus Life Sciences Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 24 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 467.08 | 466.70 | 0.08% | 409.69 | 14.01% |
| Depreciation/ Amortization | 15.97 | 15.16 | 5.35% | 14.53 | 9.88% |
| Operating Income | 182.46 | 175.15 | 4.18% | 126.91 | 43.77% |
| Net Income | 141.87 | 136.96 | 3.58% | 97.94 | 44.86% |
| Other Operating Expenses Total | 101.80 | 100.57 | 1.21% | 84.20 | 20.90% |
| Net Income Before Taxes | 191.29 | 185.15 | 3.32% | 129.68 | 47.51% |
| Total Revenue | 649.55 | 641.84 | 1.20% | 536.60 | 21.05% |
| Selling/ General/ Admin Expenses Total | 66.72 | 65.69 | 1.57% | 72.26 | -7.66% |
| Diluted Normalized EPS | 11.55 | 11.14 | 3.68% | 7.97 | 44.97% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.